Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. [electronic resource] by
- O'Neill, W W
- Serruys, P
- Knudtson, M
- van Es, G A
- Timmis, G C
- van der Zwaan, C
- Kleiman, J
- Gong, J
- Roecker, E B
- Dreiling, R
- Alexander, J
- Anders, R
Producer: 20000504
In:
The New England journal of medicine vol. 342
Availability: No items available.
|
|
|
12.
|
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial. [electronic resource] by
- Kereiakes, D J
- Kleiman, N S
- Ferguson, J J
- Masud, A R
- Broderick, T M
- Abbottsmith, C W
- Runyon, J P
- Anderson, L C
- Anders, R J
- Dreiling, R J
- Hantsbarger, G L
- Bryzinski, B
- Topol, E J
Producer: 19981022
In:
Circulation vol. 98
Availability: No items available.
|